.

S69 - LPL BARRACKPORE

8(4/D) & 22/2, Barasat Road, P.O - N.C Pukur

Name : Mrs. DIPALI GHOSH Collected : 3/9/2019 8:45:00AM

Received : 3/9/2019 11:22:11AM
Lab No. : 262679761 Age: 70 Years Gender: Female Reported : 3/9/2019 7:17:31PM
A/c Status : P Ref By : Dr. MALAY GHOSH Report Status : Final

Test Name Results Units Bio. Ref. Interval

LIPID PROFILE, BASIC, SERUM

(Spectrophotometry)
Cholesterol Total 220.00 mg/dL <200.00

Triglycerides 105.00 mg/dL <150.00

HDL Cholesterol 51.00 mg/dL >50.00

LDL Cholesterol 148.00 mg/dL <100.00

VLDL Cholesterol 21.00 mg/dL <30.00

Non-HDL Cholesterol 169.00 mg/dL <130.00

Interpretation
-----------------------------------------------------------------------------------
| NATIONAL LIPID | TOTAL | TRIGLYCERIDE | LDL CHOLESTEROL |NON HDL |
| ASSOCIATION | CHOLESTEROL | in mg/dL | in mg/dL |CHOLESTEROL |
| RECOMMENDATIONS | in mg/dL | | |in mg/dL |
| (NLA-2014) | | | | |
|-------------------|---------------|--------------|-----------------|--------------|
| Optimal | <200 | <150 | <100 | <130 |
|-------------------|---------------|--------------|-----------------|--------------|
| Above Optimal | - | - | 100- 129 | 130 - 159 |
|-------------------|---------------|--------------|-----------------|--------------|
| Borderline High | 200-239 | 150-199 | 130-159 | 160 - 189 |
|-------------------|---------------|--------------|-----------------|--------------|
| High | >=240 | 200-499 | 160-189 | 190 - 219 |
|-------------------|---------------|--------------|-----------------|--------------|
| Very High | - | >=500 | >=190 | >=220 |
-----------------------------------------------------------------------------------

Note
1. Measurements in the same patient can show physiological& analytical variations. Three serial samples
1 week apart are recommended for Total Cholesterol, Triglycerides, HDL& LDL Cholesterol.
2. As per NLA-2014 guidelines, all adults above the age of 20 years should be screened for lipid status.
PatientReportSCSuperPanel.GENERAL_PANEL_ANALYTE_SC (Version: 6)

*262679761*
Page 1 of 7
.

S69 - LPL BARRACKPORE

8(4/D) & 22/2, Barasat Road, P.O - N.C Pukur

Name : Mrs. DIPALI GHOSH Collected : 3/9/2019 8:45:00AM

Received : 3/9/2019 11:22:11AM
Lab No. : 262679761 Age: 70 Years Gender: Female Reported : 3/9/2019 7:17:31PM
A/c Status : P Ref By : Dr. MALAY GHOSH Report Status : Final

Test Name Results Units Bio. Ref. Interval

Selective screening of children above the age of 2 years with a family history of premature
cardiovascular disease or those with at least one parent with high total cholesterol is recommended.
3. Low HDL levels are associated with increased risk forAtherosclerotic Cardiovascular disease (ASCVD)
due to insufficient HDL being available to participate in reverse cholesterol transport, the process by
which cholesterol is eliminated from peripheral tissues.
4. NLA-2014identifies Non HDL Cholesterol(an indicator of all atherogeniclipoproteins such as LDL , VLDL,
IDL, Lpa, Chylomicron remnants)along with LDL-cholesterol as co- primary target for cholesterol
lowering therapy. Note that major risk factors can modify treatment goals for LDL &Non HDL.
5. Apolipoprotein B is an optional, secondary lipid target for treatment once LDL & Non HDL goals have
been achieved.
6. Additional testing for Apolipoprotein B, hsCRP,Lp(a ) & LP-PLA2 should be considered among patients
with moderate risk for ASCVD for risk refinement

Treatment Goals as per Lipid Association of India 2016

-----------------------------------------------------------------------------------------
| | CONSIDER THERAPY | TREATMENT GOAL |
| |-------------------------------------|-------------------------------------|
| RISK CATEGORY| LDL CHOLESTEROL| NON HDL CHLOESTEROL| LDL CHOLESTEROL| NON HDL CHLOESTEROL|
| | (LDL-C)(mg/dL) | (NON HDL-C) (mg/dL)| (LDL-C)(mg/dL) |(NON HDL-C) (mg/dL |
|--------------|----------------|--------------------|----------------|--------------------|
| Very High | >=50 | >=80 | <50 | <80 |
|--------------|----------------|--------------------|----------------|--------------------|
| High | >=70 | >=100 | <70 | <100 |
|--------------|----------------|--------------------|----------------|--------------------|
| Moderate | >=100 | >=130 | <100 | <130 |
|--------------|----------------|--------------------|----------------|--------------------|
| Low | >=130* | >=160* | <100 | <130 |
------------------------------------------------------------------------------------------
*In low risk patient, consider therapy after an initial non-pharmacological
intervention for at least 3 months

LIVER PANEL 1; LFT,SERUM

(Spectrophotometry)
AST (SGOT) 33 U/L 15.00 - 37.00

ALT (SGPT) 40 U/L 30 - 65

PatientReportSCSuperPanel.GENERAL_PANEL_ANALYTE_SC (Version: 6)

*262679761*
Page 2 of 7
.

S69 - LPL BARRACKPORE

8(4/D) & 22/2, Barasat Road, P.O - N.C Pukur

Name : Mrs. DIPALI GHOSH Collected : 3/9/2019 8:45:00AM

Received : 3/9/2019 11:22:11AM
Lab No. : 262679761 Age: 70 Years Gender: Female Reported : 3/9/2019 7:17:31PM
A/c Status : P Ref By : Dr. MALAY GHOSH Report Status : Final

Test Name Results Units Bio. Ref. Interval

AST:ALT Ratio 0.83 <1.00

GGTP 44 U/L 5 - 55

Alkaline Phosphatase (ALP) 144 U/L 50 - 136

Bilirubin Total 0.48 mg/dL <1.00

Bilirubin Direct 0.08 mg/dL 0.00 - 0.30

Bilirubin Indirect 0.40 mg/dL <1.10

Total Protein 7.70 g/dL 6.40 - 8.20

Albumin 3.90 g/dL 3.4 - 5.0

A : G Ratio 1.03 0.90 - 2.00

Note
1. In an asymptomatic patient, Non alcoholic fatty liver disease (NAFLD) is the most common cause of
increased AST, ALT levels. NAFLD is considered as hepatic manifestation of metabolic syndrome.
2. In most type of liver disease, ALT activity is higher than that of AST; exception may be seen in Alcoholic
Hepatitis, Hepatic Cirrhosis, and Liver neoplasia. In a patient with Chronic liver disease, AST:ALT
ratio>1 is highly suggestive of advanced liver fibrosis.
3. In known cases of Chronic Liver disease due to Viral Hepatitis B & C, Alcoholic liver disease or NAFLD,
Enhanced liver fibrosis (ELF) test may be used to evaluate liver fibrosis.
4. In a patient with Chronic Liver disease, AFP and Des-gamma carboxyprothrombin (DCP)/PIVKA II can
be used to assess risk for development of Hepatocellular Carcinoma.

PatientReportSCSuperPanel.GENERAL_PANEL_ANALYTE_SC (Version: 6)

*262679761*
Page 3 of 7
.

S69 - LPL BARRACKPORE

8(4/D) & 22/2, Barasat Road, P.O - N.C Pukur

Name : Mrs. DIPALI GHOSH Collected : 3/9/2019 8:45:00AM

Received : 3/9/2019 11:22:11AM
Lab No. : 262679761 Age: 70 Years Gender: Female Reported : 3/9/2019 7:17:31PM
A/c Status : P Ref By : Dr. MALAY GHOSH Report Status : Final

Test Name Results Units Bio. Ref. Interval

PatientReportSCSuperPanel.GENERAL_PANEL_ANALYTE_SC (Version: 6)

*262679761*
Page 4 of 7
.

S69 - LPL BARRACKPORE

8(4/D) & 22/2, Barasat Road, P.O - N.C Pukur

Name : Mrs. DIPALI GHOSH Collected : 3/9/2019 8:45:00AM

Received : 3/9/2019 11:22:11AM
Lab No. : 262679761 Age: 70 Years Gender: Female Reported : 3/9/2019 7:17:31PM
A/c Status : P Ref By : Dr. MALAY GHOSH Report Status : Final

Test Name Results Units Bio. Ref. Interval

URIC ACID, SERUM 4.90 mg/dL 2.6 - 6.0
(Uricase)

GLUCOSE, FASTING (F), PLASMA 108.00 mg/dL 70.00 - 100.00

(Hexokinase)

CREATININE, SERUM 0.76 mg/dL 0.6 - 1.0

(Compensated Jaffe's reaction, IDMS traceable)

UREA, SERUM 33.00 mg/dL 14.9 - 38.5

(Urease UV)

SODIUM, SERUM 133.00 mEq/L 136.00 - 146.00

(Indirect ISE)

POTASSIUM, SERUM 4.70 mEq/L 3.50 - 5.10

(Indirect ISE)

PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 7)

*262679761*
Page 5 of 7
.

S69 - LPL BARRACKPORE

8(4/D) & 22/2, Barasat Road, P.O - N.C Pukur

Name : Mrs. DIPALI GHOSH Collected : 3/9/2019 8:45:00AM

Received : 3/9/2019 11:22:11AM
Lab No. : 262679761 Age: 70 Years Gender: Female Reported : 3/9/2019 7:17:31PM
A/c Status : P Ref By : Dr. MALAY GHOSH Report Status : Final

Test Name Results Units Bio. Ref. Interval

COMPLETE BLOOD COUNT;CBC

(Electrical Impedance & Flow)

Hemoglobin 12.60 g/dL 11.50 - 15.00

Packed Cell Volume (PCV) 38.90 % 36.00 - 46.00

RBC Count 4.18 mill/mm3 3.80 - 4.80

MCV 93.10 fL 80.00 - 100.00

MCH 30.10 pg 27.00 - 32.00

MCHC 32.40 g/dL 32.00 - 35.00

Red Cell Distribution Width (RDW) 15.30 % 11.50 - 14.50

Total Leukocyte Count (TLC) 5.24 thou/mm3 4.00 - 10.00

Differential Leucocyte Count (DLC)

Segmented Neutrophils 49.80 % 40.00 - 80.00

Lymphocytes 40.30 % 20.00 - 40.00
Monocytes 2.50 % 2.00 - 10.00
Eosinophils 7.40 % 1.00 - 6.00
Basophils 0.00 % <2.00
Absolute Leucocyte Count

Neutrophils 2.61 thou/mm3 2.00 - 7.00

Lymphocytes 2.11 thou/mm3 1.00 - 3.00
Monocytes 0.13 thou/mm3 0.20 - 1.00
Eosinophils 0.39 thou/mm3 0.02 - 0.50
Basophils 0.00 thou/mm3 0.01 - 0.10
Platelet Count 204.0 thou/mm3 150.00 - 450.00

*262679761*
Page 6 of 7
.

S69 - LPL BARRACKPORE

8(4/D) & 22/2, Barasat Road, P.O - N.C Pukur

Name : Mrs. DIPALI GHOSH Collected : 3/9/2019 8:45:00AM

Received : 3/9/2019 11:22:11AM
Lab No. : 262679761 Age: 70 Years Gender: Female Reported : 3/9/2019 7:17:31PM
A/c Status : P Ref By : Dr. MALAY GHOSH Report Status : Final

Test Name Results Units Bio. Ref. Interval

Mean Platelet Volume (MPV) 13.90 fL 6.50 - 12.00

Note
1. As per the recommendation of International council for Standardization in Hematology, the differential
leucocyte counts are additionally being reported as absolute numbers of each cell in per unit volume of
blood

2. Test conducted on EDTA whole blood

Dr Chiranjit Biswas
MD, Pathology
Chief of Laboratory
Dr Lal PathLabs Ltd

-------------------------------End of report --------------------------------

IMPORTANT INSTRUCTIONS

*Test results released pertain to the specimen submitted .*All test results are dependent on the quality of the sample received by the Laboratory .
*Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the Referring Physician .*Sample
repeats are accepted on request of Referring Physician within 7 days post reporting.*Report delivery may be delayed due to unforeseen
circumstances. Inconvenience is regretted.*Certain tests may require further testing at additional cost for derivation of exact value. Kindly submit
request within 72 hours post reporting.*Test results may show interlaboratory variations .*The Courts/Forum at Delhi shall have exclusive
jurisdiction in all disputes/claims concerning the test(s) & or results of test(s).*Test results are not valid for medico legal purposes. * Contact
customer care Tel No. +91-11-39885050 for all queries related to test results.
(#) Sample drawn from outside source.

*262679761*
Page 7 of 7